Public Profile

Organabio, LLC

Organabio, LLC, headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in innovative solutions for the life sciences industry. Founded in 2015, Organabio has rapidly established itself as a leader in organoid technology, providing unique products and services that enhance research capabilities in drug discovery and disease modelling. With a focus on high-quality organoid models, Organabio's offerings stand out due to their precision and reproducibility, catering to researchers and pharmaceutical companies alike. The company has achieved significant milestones, including collaborations with major academic institutions and contributions to groundbreaking studies. As a trusted partner in the biotechnology field, Organabio continues to drive advancements that support the evolving needs of the scientific community.

DitchCarbon Score

How does Organabio, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

Organabio, LLC's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Organabio, LLC's reported carbon emissions

Organabio, LLC, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed information, it is essential to monitor future disclosures from Organabio regarding their climate commitments and any potential strategies they may implement to reduce their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Organabio, LLC's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Organabio, LLC is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Organabio, LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Medical Device Manufacturing

II-VI Singapore Pte., Ltd.

SG
Medical Device Manufacturing
Updated 3 days ago
CDP

Krka

SI
Medical Device Manufacturing
Updated 11 days ago

Inter Pharma

TH
Medical Device Manufacturing
Updated 11 days ago

Bruker Daltonics Inc.

US
Medical Device Manufacturing
Updated 3 days ago

Tianjin Samsung Corning Co., Ltd.

CN
Medical Device Manufacturing
Updated 3 days ago

Younger Optics Europe

CZ
Medical Device Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers